PROPHYLAXIS OF BACTERIAL MENINGITIS

van Alphen, 1997, Effect of nationwide vaccination of 3-month-old infants in The Netherlands with conjugate Haemophilus influenzae type b vaccine: High efficacy and lack of herd immunity, J Pediatr, 131, 869, 10.1016/S0022-3476(97)70035-0 Amata, 1974, Serologic response to serogroup C meningococcal polysaccharide in Brazilian preschool children, Rev Inst Med Trop São Paulo, 16, 149 American Academy of Pediatrics, 1984, Revision of recommendation for use of rifampin prophylaxis of contacts of patients with Haemophilus influenzae infection, Pediatrics, 74, 301 American Academy of Pediatrics, 1996, Meningococcal disease prevention and control strategies for practice-based physicians, Pediatrics, 97, 404 Anderson, 1994, Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults, Infect Immun, 62, 3391, 10.1128/IAI.62.8.3391-3395.1994 Artenstein, 1970, Prevention of meningococcal meningitis by group C polysaccharide vaccine, N Engl J Med, 282, 417, 10.1056/NEJM197002192820803 Austrian, 1976, Prevention of pneumococcal pneumonia by vaccination, Transactions of the Association of American Phys, 89, 184 Band, 1984, Prevention of Haemophilus influenzae type b disease, JAMA, 251, 2381, 10.1001/jama.251.18.2381 Barnett, 1996, Response to quadrivalent meningococcal vaccine in children less than 2 years of age [abstract], Pediatr Res, 39, 166, 10.1203/00006450-199604001-01005 Bartoloni, 1995, Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide, Vaccine, 13, 463, 10.1016/0264-410X(94)00007-A Begg, 1995, Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type b conjugate vaccines given for primary immunisation by separate or mixed injection, Vaccine, 13, 1547, 10.1016/0264-410X(95)00091-E Bennett, 1993, Cockroaches as carriers of bacteria, Lancet, 341, 732, 10.1016/0140-6736(93)90497-5 Bjune, 1991, Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway, Lancet, 338, 1093, 10.1016/0140-6736(91)91961-S Black, 1991, Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children, Pediatr Infect Dis J, 10, 97, 10.1097/00006454-199102000-00004 Black SB, Shinefield HE, Ray P, et al: Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: Results of the Northern California Kaiser Permanenete Efficacy Trial [abstract LB-9]. In Programs and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, 1998, p 23 Bolan, 1986, Pneumococcal vaccine efficacy in selected populations in the United States, Ann Intern Med, 104, 1, 10.7326/0003-4819-104-1-1 Booy, 1994, Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T, Lancet, 344, 362, 10.1016/S0140-6736(94)91400-1 Brandt, 1975, Duration of antibody responses after vaccination with group C Neisseria meningitidis polysaccharide, J Infect Dis, 131, 569, 10.1093/infdis/131.Supplement.S69 Butler, 1993, Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations, JAMA, 270, 1826, 10.1001/jama.270.15.1826 Ceesay, 1993, Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization, J Infect Dis, 167, 1212, 10.1093/infdis/167.5.1212 Centers for Disease Control, 1995, Serogroup B meningococcal disease—Oregon, 1994, MMWR Morb Mortal Wkly Rep, 44, 121 Cochi, 1986, Primary invasive Haemophilus influenzae type b disease: A population-based assessment of risk factors, J Pediatr, 108, 887, 10.1016/S0022-3476(86)80922-2 Cohen, 1991, Reduction of transmission of shigellosis by control of houseflies (Musca domestica), Lancet, 337, 993, 10.1016/0140-6736(91)92657-N Cordeiro, 1995, Eficacia poslicenciamiento de VA-MENGOC-BC en menores de 6 años en Holguín, Cuba. Primer año de observación, Rev Cubana Med Trop, 47, 59 Costa E de, 1995, On the controversy abut the efficacy of the antimeningococcal B vaccine: Methodological pitfalls, Cadernos de Saúde Pública (Rio de Janeiro), 11, 332, 10.1590/S0102-311X1995000200018 Costa E de, 1996, Avaliação da proteção conferidda pela vacina antimenigocócica BC no Estado de Santa Catarina, Brazil, 1990/92, Rev Saúde Pública, 30, 460, 10.1590/S0034-89101996000500009 Costa, 1997, Effectiveness of meningococcal vaccine in Brazil, Int J Epidemiol, 26, 681, 10.1093/ije/26.3.681b Dagan, 1992, Epidemiology of invasive childhood pneumococcal infection in Israel, JAMA, 268, 3328, 10.1001/jama.268.23.3328 Dagan, 1996, Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococal vaccine, J Infect Dis, 174, 1271, 10.1093/infdis/174.6.1271 Dagan, 1998, Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants, Infect Immun, 66, 2093, 10.1128/IAI.66.5.2093-2098.1998 Debbag R, Rüttimann R, Stamboulian D: Evaluation of adverse reactions associated to antimeningococcal BC vaccination in 16,700 children [abstract 420]. In Programs and Abstracts of the 33th Annual Meeting of the Infectious Diseases Society of America, San Francisco, 1997, p 790 De Moraes, 1992, Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil, Lancet, 340, 1074, 10.1016/0140-6736(92)93086-3 De Wals, 1981, Meningococcal disease in Belgium. Secondary attack-rate among household, day-care nursery and pre-elementary school contacts, J Infect Dis, 3, 53 De Wals, 1996, Impact of a mass immunization campaign against serogroup C meningococcus in the province of Quebec, Canada, Bull World Health Organ, 74, 407 Echániz-Aviles, 1995, Capsular types of Streptococcus pneumoniae causing disease in children from Mexico City, Pediatr Infect Dis J, 14, 907, 10.1097/00006454-199510000-00019 Erwa, 1973, A serogroup A meningococcal polysaccharide vaccine, Bull World Health Organ, 49, 301 Eskola, 1987, Secondary cases of invasive disease caused by spread of Haemophilus influenzae type b, J Infect, 14, 233, 10.1016/S0163-4453(87)93460-8 Eskola, 1992, Epidemiology of invasive preumococcal infections in children in Finland, JAMA, 268, 3323, 10.1001/jama.268.23.3323 Eskola, 1990, A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease, N Engl J Med, 323, 1381, 10.1056/NEJM199011153232004 Eskola, 1997, Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine, Lancet, 348, 1688, 10.1016/S0140-6736(96)04356-5 Fairley, 1996, Conjugate meningococcal serogroup A and C vaccine: Reactogenicity and immunogenicity in United Kingdom infants, J Infect Dis, 174, 1360, 10.1093/infdis/174.6.1360 Feigin, 1982, Epidemic meningococcal disease in an elementary-school classroom, N Engl J Med, 307, 1255, 10.1056/NEJM198211113072007 Fedson, 1994, Pneumococcal vaccine after 15 years of use: Another view, Arch Intern Med, 154, 2531, 10.1001/archinte.154.22.2531 Finne, 1983, Antigenic similarities between brain components and bacteria causing meningitis: Implications for vaccine development and pathogenesis, Lancet, 2, 355, 10.1016/S0140-6736(83)90340-9 Firgis, 1998, Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis, Ped Infect Dis J, 17, 816, 10.1097/00006454-199809000-00013 Flexner, 1913, The results of serum treatment in 1300 cases of epidemic meningitis, J Exp Med, 17, 553, 10.1084/jem.17.5.553 Fraser, 1997, Bacterial meningitis in Bernalillo County, New Mexico: A comparison with three other American populations, Am J Epidemiol, 100, 29, 10.1093/oxfordjournals.aje.a112005 Gaston, 1986, Prophylaxis with oral penicillin in children with sickle cell anemia, N Engl J Med, 314, 1593, 10.1056/NEJM198606193142501 Gilbert, 1991, Rifampicin prophylaxis for throat carriage of Haemophilus influenzae type b in patients with invasive disease and their contacts, BMJ, 302, 1432, 10.1136/bmj.302.6790.1432 Gilja, 1993, Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis, Antimicrob Agents Chemother, 7, 2024, 10.1128/AAC.37.9.2024 Glode, 1982, Commentary: What price orange urine?, Pediatr Infect Dis, 1, 40, 10.1097/00006454-198203000-00017 Gold, 1971, Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969–1970, Bull World Health Organ, 45, 279 Goldschneider, 1969, Human immunity to the meningococcus. II. The development of natural immunity, J Exp Med, 129, 1327, 10.1084/jem.129.6.1327 Gotschlich, 1969, Human immunity to the meningococcus. III. Preparation and biochemical properties of the group A, group B and group C meningococcal polysaccharide, J Exp Med, 129, 1349, 10.1084/jem.129.6.1349 Gotschlich, 1975, Development of polysaccharide vaccines for the prevention of meningococcal diseases, Monogr Allergy, 9, 245 Granoff, 1998, Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination, J Infect Dis, 178, 870, 10.1086/515346 Gray, 1992, Meningococcal disease: Was Ottawa's mass-vaccination program necessary?, Can Med Assoc J, 146, 1033 Greenfield, 1971, Meningococcal carriage in a population of “normal” families, J Infect Dis, 23, 67, 10.1093/infdis/123.1.67 Greenwood, 1981, Enhancement of the immune response to meningococcal polysaccharide vaccine in a malaria endemic area by administration of chloroquine, Ann Trop Med Parasitol, 75, 261, 10.1080/00034983.1981.11687439 Guttler, 1971, Effect of rifampicin and minocycline on meningococcal carrier rates, J Infect Dis, 124, 199, 10.1093/infdis/124.2.199 Heidelberger, 1948, The human antibody response to simultaneous injection of six specific polysaccharides of pneumococci, J Exp Med, 88, 369, 10.1084/jem.88.3.369 Hoge, 1994, An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail, N Engl J Med, 331, 543, 10.1056/NEJM199409083311004 Hoppenbrouers, 1998, Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DPT) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile, Vaccine, 16, 921, 10.1016/S0264-410X(97)00303-4 Hume, 1992, Mass voluntary immunization campaigns form meningococcal disease in Canada: Media hysteria, JAMA, 267, 1833, 10.1001/jama.267.13.1833 Jackson, 1995, Serogroup C meningococcal outbreaks in the United States. An emerging threat, JAMA, 273, 383, 10.1001/jama.273.5.383 Jackson, 1995, Should college students be vaccinated against meningococcal disease? A cost-benefit analysis, Am J Public Health, 85, 843, 10.2105/AJPH.85.6.843 Jacobson, 1976, The risk of meningitis among classroom contacts during an epidemic of meningococcal disease, Am J Epidemiol, 104, 552, 10.1093/oxfordjournals.aje.a112329 Jónsdóttir, 1992, Immunizaton of infants in Iceland against Haemophilus influenzae type b, Lancet, 340, 252, 10.1016/0140-6736(92)90529-C Kaiser, 1974, Seroepidemiology and chemoprophylaxis of diseases due to sulfonamide-resistant Neisseria meningitidis in a civilian population, J Infect Dis, 130, 217, 10.1093/infdis/130.3.217 Kauppi, 1995, Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines, Pediatr Infect Dis J, 14, 286, 10.1097/00006454-199504000-00008 Käyhty, 1980, Serum antibodies to capsular polysaccharide vaccine of group A Neisseria meningitidis followed for three years in infants and children, J Infect Dis, 142, 861, 10.1093/infdis/142.6.861 Käyhty, 1983, The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b, J Infect Dis, 147, 1100, 10.1093/infdis/147.6.1100 Käyhty, 1989, Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age, Pediatrics, 84, 995 King, 1996, Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children, J Pediatr, 128, 196, 10.1016/S0022-3476(96)70389-X Koskela, 1986, Antibody response of young children to parenteral vaccination with pneumococcal capsular polysaccharides: A comparison between antibody levels in serum and middle ear effusion, Pediatr Infect Dis J, 5, 431, 10.1097/00006454-198607000-00011 Kristiansen, 1998, Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study, BMJ, 317, 621, 10.1136/bmj.317.7159.621 Kuhns, 1943, The prophylactic value of sulfadiazine in the control of meningococcic meningitis, JAMA, 1234, 335, 10.1001/jama.1943.02840410017006 Lagos, 1998, Economisation of vaccination against Haemophilus influenzae type b: A randomised trial of immunogenicity of fractional-dose and two-dose regimens, Lancet, 351, 1472, 10.1016/S0140-6736(97)07456-4 Lapeyssonie, 1963, La méningite cérébro-spinale en Afrique, Bull World Health Organ, 28, 1 Leach, 1997, Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine, J Infect Dis, 175, 200, 10.1093/infdis/175.1.200 Lennon, 1992, Successful intervention in a group A meningococcal outbreak in Auckland, New Zealand, Pediatr Infect Dis J, 11, 617 Lepow, 1977, Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines, Pediatrics, 60, 673 Lifely, 1986, Vaccine against meningococcal group B disease, Lancet, 1, 214, 10.1016/S0140-6736(86)90690-2 MacDonald N, Halperin S, Law B, et al: Immunization of toddlers with ChironR conjugated meningococcal C (MenC) vaccine induces immunologic memory while plain Men polysaccharide (PS) vaccine induces tolerance [abstract G-3]. In Programs and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, 1997, p 192 MacLeod, 1945, Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides, J Exp Med, 82, 445, 10.1084/jem.82.6.445 Mäkelä, 1977, Polysaccharide vaccines of group A Neisseria meningitidis and Haemophilus influenzae type b: A field trial in Finland, J Infect Dis, 136, S43, 10.1093/infdis/136.Supplement.S43 Mann, 1983, New Haemophilus influenzae type b control strategy: Premature commitment to prophylaxis?, Pediatrics, 72, 118 Mayon-White, 1994, Protection for the asplenic patient, Prescribers Journal, 34, 165 McCormick, 1980, Antibody response to serogroup A and C meningococcal vaccines in infants born to mothers vaccinated during pregnancy, J Clin Invest, 65, 1141, 10.1172/JCI109768 Miller MA, Wenger J, Rosenstein N, et al: Evaluation of meningococcal meningitis control strategies for the Meningitis Belt in Africa [abstract K-127]. In Programs and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, 1997, p 350 Mulholland, 1997, Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine prevention of pneumonia and meningitis in Gambian infants, Lancet, 349, 1191, 10.1016/S0140-6736(96)09267-7 Munford, 1974, Spread of meningococcal infection within households, Lancet, 1, 1275, 10.1016/S0140-6736(74)90022-1 Nishioka S de, 1996, Effectiveness of BC meningococcal vaccine in Brazil, Int J Epidemiol, 25, 1102, 10.1093/ije/25.5.1102 Noronha, 1995, Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: A case-control study, Int J Epidemiol, 24, 1050, 10.1093/ije/24.5.1050 Nuorti, 1998, An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents, N Engl J Med, 38, 1861, 10.1056/NEJM199806253382601 Osterholm, 1984, Does rifampin prophylaxis prevent disease caused by Haemophilus influenzae type b?, JAMA, 251, 2408, 10.1001/jama.251.18.2408b Peltola, 1977, Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age, N Engl J Med, 297, 686, 10.1056/NEJM197709292971302 Peltola, 1982, Meningococcal disease—still with us, Rev Infect Dis (Clinical Infectious Diseases), 5, 71, 10.1093/clinids/5.1.71 Peltola, 1982, Shift in the age-distribution of meningococcal diseases as predictor of an epidemic?, Lancet, 2, 595, 10.1016/S0140-6736(82)90669-9 Peltola, 1992, Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines, Lancet, 340, 592, 10.1016/0140-6736(92)92117-X Peltola, 1997, Vaccines Against Bacterial Meningitis, 1013 Peltola, 1998, Meningococcal vaccines. Current status and future possibilities, Drugs, 55, 347, 10.2165/00003495-199855030-00003 Peltola, 1982, Shift in the age-distribution of meningococcal diseases as predictor of an epidemic?, Lancet, 2, 595, 10.1016/S0140-6736(82)90669-9 Peltola, 1985, Evaluation of two tetravelent (ACYW135) meningococcal vaccines in infants and small children. A clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides, Pediatrics, 76, 91, 10.1542/peds.76.1.91 Peltoa, 1989, Randomised comparison of chloramphenicol, ampicillin, cefotaxime and ceftriaxone for childhood bacterial meningitis, Lancet, 1, 1281, 10.1016/S0140-6736(89)92685-8 Peltola, 1999, Perspective: A five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia, J Infect Dis, 179, 223, 10.1086/314535 Peltola, 1997, Haemophilus influenzae type b disease and vaccination in Latin America and The Caribbean, Pediatr Infect Dis J, 16, 780, 10.1097/00006454-199708000-00010 Perkins, 1998, Immunogenicity of two efficaceous outer membrane protein-based serogroup B meningococcal vaccines among adults in Iceland, J Infect Dis, 177, 683, 10.1086/514232 Powers, 1996, Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults, J Infect Dis, 173, 1014, 10.1093/infdis/173.4.1014 Pugsley, 1987, Efficiency of ciprofloxacin in the treatment of nasopharyngeal carriers of Neisseria meningitidis, J Infect Dis, 156, 211, 10.1093/infdis/156.1.211 1997, Recommendations of the Advisory Committee on Immunization Practices (ACIP): Prevention of pneumococcal disease, MMWR Morb Mortal Wkly Rep, 46, RR-8 1997, Recommendations of the Advisory Committee on Immunization Practices (ACIP): Control and prevention of meningococcal disease, and control and prevention of serogroup C meningococcal disease: Evaluation and management of suspected outbreaks, MMWR Morb Mortal Wkly Rep, 46, 1 Reingold, 1985, Age-specific differences in duration of clinical protection after vaccinations with meningococcal polysaccharide A vaccine, Lancet, 2, 114, 10.1016/S0140-6736(85)90224-7 Renkonen, 1987, Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits of Finland, Antimicrob Agents Chemother, 31, 962, 10.1128/AAC.31.6.962 Rosenstein, 1998, Efficacy of meningococcal vaccine and barriers to vaccination, JAMA, 279, 435, 10.1001/jama.279.6.435 Sáez-Llorens, 1885, Intrapartum prophylaxis ith ceftriaxone decreases rates of bacterial colonization and early-onset infection in newborns, Clin Infect Dis, 21, 876, 10.1093/clinids/21.4.876 Salmi, 1976, An epidemic due to sulphonamide-resistant group A meningococci in the Helsinki area (Finland). Epidemiological and clinical observations, Scand J Infect Dis, 8, 249, 10.3109/inf.1976.8.issue-4.06 Sankilampi, 1997, Persistence of antibodies to pneumococcal capsular polysaccharide vaccine in the elderly, J Infect Dis, 176, 1100, 10.1086/516521 Santosham, 1991, The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex, N Engl J Med, 324, 1767, 10.1056/NEJM199106203242503 Schwartz, 1988, Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis, Lancet, 1, 1239, 10.1016/S0140-6736(88)92069-7 Shann, 1998, Pneumococcal vaccine: Time for another controlled trial, Lancet, 351, 1600, 10.1016/S0140-6736(05)77683-2 Shapiro, 1991, The protective efficacy of polyvalent pneumococcal polysaccharide vaccine, N Engl J Med, 325, 1453, 10.1056/NEJM199111213252101 Sierra, 1991, Vaccine against group B Neisseria meningitidis: Protection trial and mass vaccination results in Cuba, National Institute for Public Health (Oslo, Norway) Annals, 14, 195 Takala, 1989, Risk factors of invasive Haemophilus influenzae type b disease among children in Finland, J Pediatr, 115, 694, 10.1016/S0022-3476(89)80644-4 Takala, 1991, Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine, J Infect Dis, 164, 982, 10.1093/infdis/164.5.982 Tappero, 1999, Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines. A randomized controlled study in Chile, JAMA, 281, 1520, 10.1001/jama.281.16.1520 Taunay, 1978, Avaliaçao do efeito protetor de vacina polissacaridica antimeningocócica do grupo C, em crianças de 6 a 36 meses, Rev Instituto Adolfo Lutz (São Paulo, Brazil), 38, 82 The Meningococcal Disease Surveillance Group, 1976, Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis, J Infect Dis, 134, 201, 10.1093/infdis/134.2.201 Turk, 1963, Naso-pharyngeal carriage of Haemophilus influenzae type b, Journal of Hygeine (Lond), 61, 247, 10.1017/S0022172400020957 Vadheim, 1994, Eradication of Haemophilus influenzae type b disease in Southern California, Arch Pediatr Adolesc Med, 148, 51, 10.1001/archpedi.1994.02170010053011 Wahdan, 1973, A controlled field trial of a serogroup A meningococcal polysaccharide vaccine, Bull World Health Organ, 48, 667 Ward, 1979, Haemophilus influenzae meningitis: A national study of secondary spread in household contacts, N Engl J Med, 301, 122, 10.1056/NEJM197907193010302 Ward, 1990, Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaskan native infants, N Engl J Med, 323, 1393, 10.1056/NEJM199011153232006 Wenger, 1990, Bacterial meningitis in the United States, 1986: Report of a multistate study, J Infect Dis, 162, 1316, 10.1093/infdis/162.6.1316 Whitney CG, Dondoc N, Enktuja B, et al: Control of epidemic serogroup A meningococcal disease, Mongolia [poster 20.011]. In Programs and Abstracts of the 7th International Congress for Infectious Diseases, Hong Kong, 1996, p 42 WHO, Fondation Marcel Mérieux: Control of epidemic meningococcal disease. WHO Practical Guidelines. Edition Fondation Marcel Mérieux, Lyon, France, 1995, ESBN 2-84039-037-X Wright, 1914, Observations on prophylactic inoculation against pneumococcus infections, and on the results achieved by it, Lancet, 1, 1, 10.1016/S0140-6736(01)56370-9 Zangwill, 1997, School-based clusters of meningococcal disease in the United States: Descriptive epidemiology and a case-control analysis, JAMA, 227, 389, 10.1001/jama.277.5.389 Zollinger, 1991, Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile, National Institute for Public Health (Oslo, Norway) Annals, 14, 211 Yagupsky, 1993, Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis, Lancet, 341, 1152, 10.1016/0140-6736(93)93171-V